Exact Mass: 331.0474
Exact Mass Matches: 331.0474
Found 36 metabolites which its exact mass value is equals to given mass value 331.0474,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Zonampanel
2-(Methylsulfonyl)-3-(6-phenyl-2,3-dihydroimidazo[2,1-b][1,3]thiazol-5-yl)acrylonitrile
2-[2-[4-(2-methyl-1,3-thiazol-4-yl)anilino]-1,3-thiazol-4-yl]acetic acid
1-cyclopropyl-8-(difluoromethoxy)-6,7-difluoro-4-oxoquinoline-3-carboxylic acid
N-(3-CHLOROPHENYL)-2-(5-(3-FLUOROPHENYL)-1,2,4-OXADIAZOL-3-YL)ACETAMIDE
Zonampanel
C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant C26170 - Protective Agent > C1509 - Neuroprotective Agent Zonampanel (YM 872) is a selective antagonist of the glutamate receptor subtype, α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor.
4-[(4-Phenyl-2-thiazolyl)amino]-benzenesulfonamide
N-(4-fluoro-3-methyl-1,3-benzothiazol-2-ylidene)-2-nitrobenzamide
(5-Hydroxy-6-Methyl-4-{[(3-Oxo-2,3-Dihydro-1,2-Oxazol-4-Yl)amino]methyl}pyridin-3-Yl)methyl Dihydrogen Phosphate
[5-Hydroxy-6-Methyl-4-({[(4e)-3-Oxo-1,2-Oxazolidin-4-Ylidene]amino}methyl)pyridin-3-Yl]methyl Dihydrogen Phosphate
8-Bromo-3-methyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-ol
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D004791 - Enzyme Inhibitors > D000067956 - Adenylyl Cyclase Inhibitors
Laricitrin(1-)
The conjugate base of laricitrin arising from deprotonation of the 3-OH group; major species at pH 7.3.
2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-6-methoxy-4-oxochromen-5-olate
N-(4-bromo-3-methylphenyl)-2,5-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine
4-(4-chlorophenyl)-3-[(4-methylphenoxy)methyl]-1H-1,2,4-triazole-5-thione
N-[4-(3-methoxyphenyl)-2-thiazolyl]-2-thiophenecarbohydrazide
2-[2-(4-Methoxyphenyl)-2-oxoethyl]-1,1-dioxo-1,2-benzothiazol-3-one
N-[4-methyl-5-[2-(2-pyridinylamino)-4-thiazolyl]-2-thiazolyl]acetamide
2-(3-thiophenyl)acetic acid [2-oxo-2-(3-oxo-4H-1,4-benzoxazin-6-yl)ethyl] ester
N-[2-(1,3-benzothiazol-2-ylthio)-1-oxoethyl]-1-methyl-2-pyrrolecarboxamide
3-(4-chlorophenyl)-N-cyclopropyl-1-methyl-5-thieno[2,3-c]pyrazolecarboxamide
2-[2-(3-bromophenoxy)ethyl]-3,4-dihydro-1H-isoquinoline
SKF-83566
SKF-83566 is a potent,?blood-brain permeable and orally active D1-like dopamine receptor (D1DR)?antagonist and a weaker competitive antagonist at the vascular 5-HT2?receptor (Ki=11 nM)[1][3]. SKF-83566 is a competitive DAT (dopamine transporter) inhibitor with an IC50?of 5.7 μM[2]. SKF-83566 also shows selective inhibition for adenylyl cyclase 2 (AC2) over AC1 and AC5 in the isolated rabbit thoracic aorta[4]. SKF-83566 can be used for research of parkinson’s disease and nicotine craving alleviation[5].
